Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 1-year Follow-up
Conditions:   Schizophrenia;   Psychotic DisordersInterventions:   Drug: Aripiprazole;   Drug: Quetiapine;   Drug: Ziprasidone;   Behavioral: Cognitive batterySponsors:   Fundación Marques de Valdecilla;   Centro de Investigación Biomédica en Red de Salud Mental;   Fundación Instituto de Investigación Marqués de Valdecilla, IDIVALCompleted - verified August 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 24, 2015 Category: Research Source Type: clinical trials